论文部分内容阅读
AIM To investigate the survival impact of clinicopathological factors,including pathological complete response(pCR)and tumor-infiltrating lymphocytes(sTIL)levels according to subtypes,in breast cancer(BC)patients who received neo-adjuvant chemotherapy(NAC